| Weatherley B, McFadyen L
Maraviroc modelling strategy: use of early phase 1 data to support a semi-mechanistic population pharmacokinetic model. [Journal Article, Research Support, Non-U.S. Gov't]
Br J Clin Pharmacol 2009 Sep; 68(3):355-69.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Edmunds-Ogbuokiri J
Optimizing care for patients on maraviroc salvage therapy. [Case Reports, Newspaper Article]
HIV Clin 2009; 21(3):11-5.
Full Citation | Find Related Articles | | Elzi L, Kaufmann G, Weber R, et al.
Discontinuation of Enfuvirtide in Heavily Pretreated HIV-Infected Individuals. [JOURNAL ARTICLE]
HIV Clin Trials 2009 Jul 1; 10(4):207-214.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | De Clercq E
The history of antiretrovirals: key discoveries over the past 25 years. [JOURNAL ARTICLE]
Rev Med Virol 2009 Aug 27; 19(5):287-299.
Abstract | Full Citation | | Abel S, Back DJ, Vourvahis M
Maraviroc: pharmacokinetics and drug interactions. [Journal Article]
Antivir Ther 2009; 14(5):607-18.
Abstract | Full Citation | Find Related Articles | | Martin J, Deslandes G, Dailly E, et al.
A liquid chromatography-tandem mass spectrometry assay for quantification of nevirapine, indinavir, atazanavir, amprenavir, saquinavir, ritonavir, lopinavir, efavirenz, tipranavir, darunavir and maraviroc in the plasma of patients infected with HIV. [JOURNAL ARTICLE]
J Chromatogr B Analyt Technol Biomed Life Sci 2009 Aug 3.
Abstract | Full Citation | Find Related Articles | | Cane PA
New developments in HIV drug resistance. [Journal Article]
J Antimicrob Chemother 2009 Sep.:i37-40.
Abstract | Full Citation | Find Related Articles | | Tilton JC, Doms RW
Entry Inhibitors in the Treatment of HIV-1 Infection. [JOURNAL ARTICLE]
Antiviral Res 2009 Aug 13.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Hughes CA, Robinson L, Tseng A, et al.
New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir. [JOURNAL ARTICLE]
Expert Opin Pharmacother 2009 Aug 13.
Abstract | Full Citation | Find Related Articles | | Genebat M, Ruiz-Mateos E, León JA, et al.
Correlation between the Trofile(R) test and virological response to a short-term maraviroc exposure in HIV-infected patients. [JOURNAL ARTICLE]
J Antimicrob Chemother 2009 Aug 11.
Abstract | Full Citation |    |
|
| |
Advertise on this site.
|
